Cargando…

Heparin and SARS-CoV-2: Multiple Pathophysiological Links

Low molecular weight heparin, enoxaparin, has been one of most used drugs to fight the SARS-CoV-2 pandemic. Pharmacological properties of heparin recognize its specific ability, as with other oligosaccharides and glycosaminoglycan, to bind several types of viruses during their pass through the extra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Micco, Pierpaolo, Imbalzano, Egidio, Russo, Vincenzo, Attena, Emilio, Mandaliti, Vincenzo, Orlando, Luana, Lombardi, Maurizio, Di Micco, Gianluca, Camporese, Giuseppe, Annunziata, Saverio, Piccinocchi, Gaetano, Pacelli, Walter, Del Guercio, Michele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705068/ https://www.ncbi.nlm.nih.gov/pubmed/34960754 http://dx.doi.org/10.3390/v13122486

Ejemplares similares

Cardiovascular Comorbidities and Pharmacological Treatments of COVID-19 Patients Not Requiring Hospitalization
por: Russo, Vincenzo, et al.
Publicado: (2020)

Pathophysiology of Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) and Vaccine-Induced Thrombocytopenic Thrombosis (VITT) and Their Diagnostic Approach in Emergency
por: Di Micco, Pierpaolo, et al.
Publicado: (2021)

Machine Learning to Calculate Heparin Dose in COVID-19 Patients with Active Cancer
por: Imbalzano, Egidio, et al.
Publicado: (2021)

Special Issue “COVID-19 and Thrombosis”
por: Di Micco, Pierpaolo, et al.
Publicado: (2022)

Editorial on the Special Issue “The New Frontier of Venous Thromboembolism”
por: Di Micco, Pierpaolo, et al.
Publicado: (2023)

Clinical Differences between COVID-19 and a COVID-Like Syndrome
por: Di Micco, Pierpaolo, et al.
Publicado: (2021)

Correction: Di Micco et al. Clinical Differences between COVID-19 and a COVID-like Syndrome. J. Clin. Med. 2021, 10, 2519
por: Di Micco, Pierpaolo, et al.
Publicado: (2022)

Case report: Successful thromboprophylaxis with enoxaparin in a pregnant woman with internal jugular vein agenesis
por: Di Micco, Pierpaolo, et al.
Publicado: (2022)

The Impact of Risk-Adjusted Heparin Regimens on the Outcome of Patients with COVID-19 Infection. A Prospective Cohort Study
por: Di Micco, Pierpaolo, et al.
Publicado: (2021)

The Impact of COVID-19 Pandemic on Hospitalization and Interventional Procedures for Cardiovascular Diseases during the First Wave in Italy
por: Russo, Vincenzo, et al.
Publicado: (2022)

Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study
por: Russo, Vincenzo, et al.
Publicado: (2020)

Prevalence of Pulmonary Hypertension in an Unselected Community-Based Population: A Retrospective Echocardiographic Study—RES-PH Study
por: Imbalzano, Egidio, et al.
Publicado: (2021)

Editorial: Vascular malformations and thrombosis
por: Di Micco, Pierpaolo, et al.
Publicado: (2023)

Sex-Specific Impact of Different Obesity/Metabolic Phenotypes on Long-Term Cardiovascular Outcomes in Acute Coronary Syndrome Patients
por: Imbalzano, Egidio, et al.
Publicado: (2022)

Editorial Comment on the Special Issue Discussing COVID-19 and Thrombosis, Second Edition
por: Di Micco, Pierpaolo, et al.
Publicado: (2023)

Natural Course of COVID-19 and Independent Predictors of Mortality
por: Orlando, Luana, et al.
Publicado: (2023)

Venous Thromboembolism and Its Association with COVID-19: Still an Open Debate
por: Di Micco, Pierpaolo, et al.
Publicado: (2020)

Clinical Outcome of Edoxaban vs. Vitamin K Antagonists in Patients with Atrial Fibrillation and Diabetes Mellitus: Results from a Multicenter, Propensity-Matched, Real-World Cohort Study
por: Russo, Vincenzo, et al.
Publicado: (2020)

Safety and Efficacy of Rivaroxaban as Extended-Phase Anticoagulation in Patients with Cancer and Venous Thromboembolism: A Preliminary Data Analysis from the Mac Project
por: Bernardi, Enrico, et al.
Publicado: (2022)

Fondaparinux and bleeding risk in COVID-19: unsolved question
por: Russo, Vincenzo, et al.
Publicado: (2021)

Safety and Efficacy of Rivaroxaban for Extended-Phase Anticoagulation of Patients with Unprovoked or Recurrent Venous Thromboembolism: Real-Life Data from the MAC Project
por: Bortoluzzi, Cristiano, et al.
Publicado: (2022)

Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients
por: Russo, Vincenzo, et al.
Publicado: (2020)

Blood Targets of Adjuvant Drugs Against COVID19
por: Di Micco, Pierpaolo, et al.
Publicado: (2020)

Pre-admission atrial fibrillation in COVID-19 patients: Prevalence and clinical impact
por: Russo, Vincenzo, et al.
Publicado: (2021)

In vitro Fertilization Procedures with Embryo Transfer and Their Association with Thrombophilia, Thrombosis and Early Antithrombotic Treatments
por: Di Micco, Pierpaolo, et al.
Publicado: (2020)

Editorial Comment on Special Issue—COVID-19 after One Year of Clinical Experience: Unexpected Clinical Presentations or Complications and Post-COVID-19 Clinical Features
por: Di Micco, Pierpaolo, et al.
Publicado: (2022)

Common Practice in the Treatment of Superficial Vein Thrombosis Involving the Sapheno-Femoral Junction: Results from a National Survey of the Italian Society of Angiology and Vascular Medicine (SIAPAV)
por: Camporese, Giuseppe, et al.
Publicado: (2023)

Idiopathic Hypereosinophilia and Venous Thromboembolism: Is There a Pathophysiological or Clinical Link? Description of an Intriguing Clinical Case
por: Di Micco, Pierpaolo, et al.
Publicado: (2020)

Clinical Outcome of Hospitalized COVID-19 Patients with History of Atrial Fibrillation
por: Russo, Vincenzo, et al.
Publicado: (2022)

Prognostic Value of Fibrinogen among COVID-19 Patients Admitted to an Emergency Department: An Italian Cohort Study
por: Di Micco, Pierpaolo, et al.
Publicado: (2020)

SV-IV Peptide1–16 reduces coagulant power in normal Factor V and Factor V Leiden
por: Di Micco, Biagio, et al.
Publicado: (2007)

Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort
por: Di Micco, Pierpaolo, et al.
Publicado: (2020)

Thematic Series on Clinical Cases on Haemostatic Disorders
por: Di Micco, Pierpaolo
Publicado: (2020)

Thrombotic Disorders and Antithrombotic Treatments Special Issue
por: Micco, Pierpaolo Di
Publicado: (2022)

Editorial: Unusual Clinical Presentation of COVID-19
por: Di Micco, Pierpaolo
Publicado: (2022)

Editorial for the Special Issue “Emergency Medicine and Emergency Room Medical Issues”
por: Di Micco, Pierpaolo
Publicado: (2023)

Further Effort is Needed to Improve Management of Chronic Pain in Primary Care. Results from the Arkys Project
por: Piccinocchi, Gaetano, et al.
Publicado: (2016)

New-Onset Atrial Fibrillation and Early Mortality Rate in COVID-19 Patients: Association with IL-6 Serum Levels and Respiratory Distress
por: Bagnato, Gianluca, et al.
Publicado: (2022)

Update on the clinical use of the low-molecular-weight heparin, parnaparin
por: Camporese, Giuseppe, et al.
Publicado: (2009)

The role of d-dimer as first marker of thrombophilia in women affected by sterility: implications in pathophysiology and diagnosis of thrombophilia induced sterility
por: Di Micco, Pierpaolo, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_jsrannukcjm901co72ue7uk3or